Physician profile
Mohammad Asif
NPI 1912954413
$2,057.14
in general payments reported to CMS, 2019-2025
19 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $158 · 2021: $272 · 2022: $721 · 2023: $281 · 2024: $143 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $583.39 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $477.79 | 2019-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $348.38 | 2019-2025 | |
| Pfizer INC. | $115.99 | 2019-2025 | |
| Abbott Laboratories | $102.60 | 2019-2025 | Dragonfly Opstar |
| Medtronic, INC. | $72.54 | 2022-2023 | Onyx Frontier |
| Medtronic Vascular, INC. | $63.02 | 2019 | |
| Boston Scientific Corporation | $48.95 | 2022-2024 | Ekosonic |
| Merck Sharp & Dohme LLC | $42.55 | 2022-2023 | Verquvo, Lagevrio |
| E.R. Squibb & Sons, L.L.C. | $37.47 | 2019-2020 | |
| Esperion Therapeutics, INC. | $28.93 | 2020-2021 | |
| Avinger INC. | $24.99 | 2019 | |
| Shockwave Medical, INC | $22.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.08 | 2022 | |
| Alnylam Pharmaceuticals INC. | $14.72 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.48 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Asif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.